Heron Therapeutics reported $-48827000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
ALKERMES ALKS:US USD -41044000 25.98M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Amarin AMRN:US USD 56.56M 93.4M
Ani Pharmaceuticals ANIP:US USD 11.9M 7.95M
Arrowhead Research ARWR:US USD -81170000 10.86M
Eisai 4523:JP JPY 7.71B 9.53B
Endo International Ordinary Shares ENDP:US USD 151.76M 22.28M
Esperion Therapeutics ESPR:US USD -41518000 10.71M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
Immunogen IMGN:US USD -77005000 16.41M
Insmed INSM:US USD -119864000 21.78M
Nektar Therapeutics NKTR:US USD -34794000 9.48M
Neurocrine Biosciences NBIX:US USD 91.8M 33.2M
Omeros OMER:US USD -50446000 13.2M
Pacira Pharmaceuticals PCRX:US USD 41.98M 7.94M
Regeneron Pharmaceuticals REGN:US USD 1.33B 49.4M
Sangamo Biosciences SGMO:US USD -51845000 8.99M
Teva Pharmaceutical Industries TEVA:US USD 1.06B 31M
Ultragenyx Pharmaceutical RARE:US USD -220372000 83.26M
Veracyte VCYT:US USD -3356000 2.42M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M